Carboplatin/Etoposide/VismodegibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69772-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：111 / 111

相关论文

共 50 条

[1] VismodegibLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 1258 - 1258
[2] Carboplatin/etoposide/streptozocinLack of efficacy: case report
Reactions Weekly, 2022, 1911 (1) : 118 - 118
[3] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 111 - 111
[4] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 114 - 114
[5] Carboplatin/etoposide/methotrexateLack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 136 - 136
[6] Carboplatin/etoposide/osimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 130 - 130
[7] Carboplatin/etoposide/topotecanLack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 126 - 126
[8] Carboplatin/etoposide/temozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1904 (1) : 133 - 133
[9] Carboplatin/etoposide/metyraponeLack of efficacy: case report
Reactions Weekly, 2024, 2028 (1) : 115 - 115
[10] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 126 - 126

← 1 2 3 4 5 →